Ossifying fibroma of maxilla – A pediatric case

---

Case Report

Author Details : Kanchan M Shah, Tejal Badhan*, Jayant S Landge, Sindhuja K

Volume : 9, Issue : 1, Year : 2023

Article Page : 57-60

https://doi.org/10.18231/j.ijohd.2023.010

Suggest article by email

Get Permission

---

Abstract

Background: Ossifying fibroma (OF) is classified as, and behaves like, a benign bone neoplasm. It is often considered to be a type of fibro-osseous lesion (FOL). It can affect both mandible and the maxilla, particularly the mandible. This bone tumour consists of highly cellular, fibrous tissue that contains varied amounts of bone or cementum resembling calcified tissue. Present case is an unusual report of ossifying fibroma involving the left side of maxilla in a 13-year old male patient, who presented to the department with a painless hard swelling. The lesion was treated by surgical enucleation and curettage.
Materials and Methods: Surgical enucleation and curettage was performed.
Results: Healing was uneventful, patient has been kept on a regular follow-up regimen.
The case report and treatment of an unusual case of Ossifying fibroma in the maxilla of a paediatric patient has been described. Based on our experience, we suggest that proper correlation of the clinical, radiological and histological features is necessary to establish a definitive diagnosis, as well as for proper surgical intervention. As reported in the literature, the rate of recurrence is not very high, but long term periodic follow-up is warranted.
 

Keywords: Ossifying fibroma, Benign, Fibro-osseous lesion, Maxilla, Enucleation, Curettage.

How to cite : Shah K M, Badhan T, Landge J S, Sindhuja K, Ossifying fibroma of maxilla – A pediatric case. Int J Oral Health Dent 2023;9(1):57-60

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.